Literature DB >> 25323141

Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study.

Mike J Crawford1, Simone Jayakumar1, Suzie J Lemmey1, Krysia Zalewska1, Maxine X Patel1, Stephen J Cooper1, David Shiers1.   

Abstract

BACKGROUND: In the UK and other high-income countries, life expectancy in people with schizophrenia is 20% lower than in the general population. AIMS: To examine the quality of assessment and treatment of physical health problems in people with schizophrenia. Method Retrospective audit of records of people with schizophrenia or schizoaffective disorder aged ⩾18. We collected data on nine key aspects of physical health for 5091 patients and combined these with a cross-sectional patient survey.
RESULTS: Body mass index was recorded in 2599 (51.1%) patients during the previous 12 months and 1102 (21.6%) had evidence of assessment of all nine key measures. Among those with high blood sugar, there was recorded evidence of 53.5% receiving an appropriate intervention. Among those with dyslipidaemia, this was 19.9%. Despite this, most patients reported that they were satisfied with the physical healthcare they received.
CONCLUSIONS: Assessment and treatment of common physical health problems in people with schizophrenia falls well below acceptable standards. Cooperation and communication between primary and secondary care services needs to improve if premature mortality in this group is to be reduced. Royal College of Psychiatrists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25323141     DOI: 10.1192/bjp.bp.113.142521

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  32 in total

Review 1.  Management of Cardiovascular Health in People with Severe Mental Disorders.

Authors:  Cédric Lemogne; Jacques Blacher; Guillaume Airagnes; Nicolas Hoertel; Sébastien Czernichow; Nicolas Danchin; Pierre Meneton; Frédéric Limosin; Jess G Fiedorowicz
Journal:  Curr Cardiol Rep       Date:  2021-01-06       Impact factor: 2.931

2.  Nature and Extent of Physical Comorbidities Among Korean Patients With Mental Illnesses: Pairwise and Network Analysis Based on Health Insurance Claims Data.

Authors:  Ho Joon Kim; Sam Yi Shin; Seong Hoon Jeong
Journal:  Psychiatry Investig       Date:  2022-06-15       Impact factor: 3.202

3.  Genetic Determinants of Clozapine-Induced Metabolic Side Effects.

Authors:  Kamini Vasudev; Yun-Hee Choi; Ross Norman; Richard B Kim; Ute I Schwarz
Journal:  Can J Psychiatry       Date:  2016-09-29       Impact factor: 4.356

4.  Strategies to deal with comorbid physical illness in psychosis.

Authors:  M Docherty; B Stubbs; F Gaughran
Journal:  Epidemiol Psychiatr Sci       Date:  2016-02-18       Impact factor: 6.892

Review 5.  Schizophrenia in a Primary Care Setting.

Authors:  Rose Jones; Barnaby Major; Christopher Fear
Journal:  Curr Psychiatry Rep       Date:  2015-10       Impact factor: 5.285

6.  Community pharmacists' attitudes and opinions towards supplying clozapine.

Authors:  Yuh-Lin Gan; Claire L O'Reilly
Journal:  Int J Clin Pharm       Date:  2018-06-23

7.  Still 'being bothered about Billy': managing the physical health of people with severe mental illness.

Authors:  Carolyn Anne Chew-Graham; Simon Gilbody; Jackie Curtis; Richard Ig Holt; Anna Kathryn Taylor; David Shiers
Journal:  Br J Gen Pract       Date:  2021-07-29       Impact factor: 6.302

8.  Big data: what it can and cannot achieve.

Authors: 
Journal:  BJPsych Adv       Date:  2018-06-06

9.  Analysis of the survival and clinical characteristics of colorectal cancer patients with mental disorders.

Authors:  Junji Kurashige; Masaaki Iwatsuki; Kosuke Mima; Daichi Nomoto; Hironobu Shigaki; Kohei Yamashita; Takeshi Morinaga; Shiro Iwagami; Nobutomo Miyanari; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2021-01-25

10.  Experiences of Hospitalization of Patients With Psychotic Disorders on Medical-Surgical Units: A Thematic Analysis.

Authors:  Guy M Weissinger; J Margo Brooks Carthon; Charisse Ahmed; Bridgette M Brawner
Journal:  J Am Psychiatr Nurses Assoc       Date:  2019-12-03       Impact factor: 2.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.